We are live on ! Find out more

Medifast

MED

Market cap $134M

12.02 USD

+0.06

0.5%

At close Updated Sep 17, 1:21 PM EDT

1 day

0.5%

5 days

-0.66%

1 month

5.07%

3 months

6.84%

6 months

19.6%

Year to date

15.58%

1 year

-14.93%

5 years

-94.53%

10 years

-68.04%

About: Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.

Employees: 380

Consumer Discretionary Personal Services

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 47.8%

Neutral 34.8%

Negative 17.4%

Zacks Investment Research

Medifast's 3.0 Strategy Takes Shape: Can It Restore Profitable Growth?

MED is shifting toward metabolic health with its 3.0 strategy, targeting broader growth, greater efficiency and a return to profitability.

Medifast's 3.0 Strategy Takes Shape: Can It Restore Profitable Growth?

Zacks Investment Research

Why Is Medifast (MED) Down 7.6% Since Last Earnings Report?

Medifast (MED) reported earnings 30 days ago. What's next for the stock?

Why Is Medifast (MED) Down 7.6% Since Last Earnings Report?

Ocius Technology to Add Sonar Systems to Bluebottle Fleet: NYSE Content Update

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Sept.

Ocius Technology to Add Sonar Systems to Bluebottle Fleet: NYSE Content Update

Medifast® Announces the Launch of the Medifast Metabolic Health Institute™

BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED) has announced the launch of the Medifast Metabolic Health Institute, established to advance metabolic health through rigorous research and credible, evidence-based education. The institute brings Medifast's clinical research, scientific expertise, and educational resources under a single body, solidifying the company's position in the metabolic health space. It follows the July launch of Trilivy™, which replaced OPTAVIA® as the company's co.

Medifast® Announces the Launch of the Medifast Metabolic Health Institute™

Zacks Investment Research

Can Medifast Capitalize on Rising GLP-1 Use With Metabolic Health?

MED's Trilivy launch marks a major metabolic-health shift, backed by a 10-year roadmap and growing GLP-1 market focus.

Can Medifast Capitalize on Rising GLP-1 Use With Metabolic Health?

Zacks Investment Research

All You Need to Know About Medifast (MED) Rating Upgrade to Buy

Medifast (MED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

All You Need to Know About Medifast (MED) Rating Upgrade to Buy

Zacks Investment Research

Can Medifast's New Compensation Plan Accelerate Coach Growth?

MED is reshaping its coach network around Executive Directors as productivity rises despite a sharp decline in active earning coaches.

Can Medifast's New Compensation Plan Accelerate Coach Growth?

Zacks Investment Research

Can Medifast's Coach Productivity Gains Help Revive Revenue Growth?

MED's improving coach productivity and client retention point to stabilization, but a shrinking coach base remains a challenge.

Can Medifast's Coach Productivity Gains Help Revive Revenue Growth?

Zacks Investment Research

Is MED Worth Buying as Low Valuation Meets a High-Risk Turnaround?

Medifast's low valuation and improving coach productivity offer potential, but a shrinking coach base and weak growth keep the turnaround high risk.

Is MED Worth Buying as Low Valuation Meets a High-Risk Turnaround?

Zacks Investment Research

MED Rallies 13.6% in the Past Month: Can the Momentum Keep Building?

Medifast stock gains 13.6% in a month as improving coach productivity and earnings expectations support momentum despite weaker revenue.

MED Rallies 13.6% in the Past Month: Can the Momentum Keep Building?

See News Rankings

Price charts implemented using Lightweight Charts™